5-[2-[4-(2-hydroxypropan-2-yl)phenyl]-1H-indol-4-yl]-2-[(3R)-pyrrolidin-3-yl]oxybenzonitrile
C28H27N3O2 — CID 118551837
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[2-[4-(2-hydroxypropan-2-yl)phenyl]-1H-indol-4-yl]-2-[(3R)-pyrrolidin-3-yl]oxybenzonitrile
5-[2-[4-(2-hydroxypropan-2-yl)phenyl]-1H-indol-4-yl]-2-[(3R)-pyrrolidin-3-yl]oxybenzonitrile (PubChem CID 118551837) has the molecular formula C28H27N3O2 and a molecular weight of 437.54 g/mol. Its IUPAC name is 5-[2-[4-(2-hydroxypropan-2-yl)phenyl]-1H-indol-4-yl]-2-[(3R)-pyrrolidin-3-yl]oxybenzonitrile.
Molecular Properties
| Compound Name | 5-[2-[4-(2-hydroxypropan-2-yl)phenyl]-1H-indol-4-yl]-2-[(3R)-pyrrolidin-3-yl]oxybenzonitrile |
|---|---|
| PubChem CID | 118551837 |
| Molecular Formula | C28H27N3O2 |
| Molecular Weight | 437.54 g/mol |
| Exact Mass | 437.21 |
| IUPAC Name | 5-[2-[4-(2-hydroxypropan-2-yl)phenyl]-1H-indol-4-yl]-2-[(3R)-pyrrolidin-3-yl]oxybenzonitrile |
| SMILES | CC(C)(O)c1ccc(-c2cc3c(-c4ccc(O[C@@H]5CCNC5)c(C#N)c4)cccc3[nH]2)cc1 |
| InChI | InChI=1S/C28H27N3O2/c1-28(2,32)21-9-6-18(7-10-21)26-15-24-23(4-3-5-25(24)31-26)19-8-11-27(20(14-19)16-29)33-22-12-13-30-17-22/h3-11,14-15,22,30-32H,12-13,17H2,1-2H3/t22-/m1/s1 |
| InChIKey | ZYYCDBHWQKIQAO-JOCHJYFZSA-N |
| XLogP | 5.34 |
| TPSA | 81.07 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 437.54 |
| LogP ≤ 5 | 5.34 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118551837 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.